Minocin Mr (Minocycline Hydrochloride)

Minocycline hydrochloride, the active ingredient in Minocin MR, is a tetracycline antibiotic presented as an extended‑release tablet for oral use. It treats bacterial infections such as acne vulgaris, respiratory tract infections, urinary tract infections, and skin and soft‑tissue infections in adolescents and adults, and is indicated for patients requiring systemic therapy.

GNH USA supplies Minocin MR as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, including both public and private healthcare sectors.

Minocin MR is used to treat bacterial infections affecting several organ systems.

- Acne vulgaris: reduces inflammatory lesions and prevents new pustules. - Respiratory tract infections: eradicates susceptible pathogens causing pneumonia and bronchitis. - Urinary tract infections: eliminates causative bacteria in uncomplicated cystitis. - Skin and soft tissue infections: treats cellulitis, abscesses and infected wounds.

Adverse reactions may occur with any antibiotic therapy.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, occasionally watery. - Photosensitivity: increased skin sensitivity to sunlight. - Dizziness: transient light‑headedness.

Serious or Rare Side Effects: - Drug‑induced lupus: systemic autoimmune reaction. - Stevens‑Johnson syndrome: severe skin and mucous membrane disorder. - Hepatic toxicity: elevated liver enzymes or hepatitis. - Severe hypersensitivity: anaphylaxis or angioedema. - Pseudotumor cerebri: increased intracranial pressure with headache and visual changes.

Use Minocin MR with appropriate clinical monitoring. - Renal function assessment: adjust use in impaired kidneys. - Hepatic monitoring: observe liver enzymes during prolonged therapy. - Pregnancy avoidance: contraindicated in pregnancy (Category D). - Pediatric caution: not recommended for children under eight years. - Concomitant photosensitizing agents: avoid excessive sun exposure. - Store at room temperature: keep in the original pack, protect from moisture.

Minocin MR can alter the activity of several co‑administered drugs.

Major Interactions (Avoid): - Isotretinoin: increased risk of intracranial hypertension. - Oral anticoagulants: enhanced anticoagulant effect, monitor INR. - Antacids containing Al/Mg: reduce minocycline absorption.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of renal impairment. - Lithium: potential for increased lithium levels and toxicity.